A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on:
Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment)
Montelukast: reminder of the risk of neuropsychiatric reactions
Letters and medicine recalls sent to healthcare professionals in April 2024.
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.
The post MHRA Drug Safety Update: April 2024 appeared first on Community Pharmacy England.